Assignee
SHANGHAI CELL THERAPY RES INST
CN·1 granted patent·3 pending applications·1 citations·filing 2016–2018
Top patents by PatentIndex Score
4 records- 0164US12042515B2Killer cell capable of efficiently and stably expressing antibody, and uses thereofSHANGHAI CELL THERAPY RES INST·Filed 2017·Granted Jul 23, 2024·1 cites·14 claims
- 0241US2021046113A1Dual-activating costimulatory molecule receptor and use thereofSHANGHAI CELL THERAPY RES INST·Filed 2018·Application pending·0 cites
- 0338US2021024927A1Chimeric promoter with high transcriptional activity in t-cellsSHANGHAI CELL THERAPY RES INST·Filed 2018·Application pending·0 cites
- 0430US2018265890A1Efficient and safe transposon integration system and use thereofSHANGHAI CELL THERAPY RES INST·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI CELL THERAPY RES INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →